Consti Oyj
CONSTI PLC MANAGERS’ TRANSACTIONS 11 MARCH 2021, at 2.00 p.m.
Consti Plc - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Sorsanen, Joni
Position: Chief Financial Officer
Issuer: Consti Plc
LEI: 743700JMXCC11CRJCS71
Notification type: INITIAL NOTIFICATION
Reference number: 743700JMXCC11CRJCS71_20210311101212_8
____________________________________________
Transaction date: 2021-03-09
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000178256
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION
Transaction details
(1): Volume: 173 Unit price: 0.00 EUR
Aggregated transactions
(1): Volume: 173 Volume weighted average price: 0.00 EUR
CONSTI PLC
Further information:
Joni Sorsanen, CFO, Consti Plc, Tel. +358 50 443 3045
Distribution:
Nasdaq Helsinki Ltd.
Major media
www.consti.fi
Consti is a leading Finnish company concentrating on renovation and technical services. Consti offers comprehensive renovation and building technology services and selected new construction services to housing companies, corporations, investors and the public sector in Finland’s growth centres. Company has four business areas: Housing Companies, Corporations, Public Sector and Building Technology. In 2020, Consti Group’s net sales amounted to 275 million euro. It employs approximately 1000 professionals in renovation construction and building technology.
Consti Plc is listed on Nasdaq Helsinki. The trading code is CONSTI. www.consti.fi
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S18.9.2025 10:45:34 CEST | Press release
Novo Nordisk A/S: Ozempic® reduces the risk of heart attack, stroke and death by 23% compared to dulaglutide in the first head-to-head real-world study
Glice AG18.9.2025 10:41:41 CEST | Press release
Europe's Leading Research Institute Confirms Breakthrough: Swiss Company Glice Develops Synthetic Ice with Real-Ice Glide
Sparinvest SICAV18.9.2025 10:40:53 CEST | Pressemeddelelse
Sparinvest SICAV suspenderer handel med afdeling
Sompo International Holdings Ltd.18.9.2025 10:30:00 CEST | Press release
Sompo appoints Alessandrea Quane as CEO, International Markets
Kitron ASA18.9.2025 10:01:45 CEST | Press release
Kitron ASA - New share capital registered
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom